Brian Marckx

Zacks Small-Cap Research

Image: Brian Marckx

Brian Marckx is the senior medical device/diagnostics analyst with Zacks Small-Cap Research, He covers small- and micro-cap medical device and diagnostic companies with a focus on development-stage companies with novel and emerging technologies, as well as already established names still flying under the radar. Prior to joining Zacks, Marckx worked as a high-yield bond analyst on Wachovia Securities' institutional trading desks, where he specialized in the healthcare and industrials industries. Prior to that he was an analyst in corporate finance at First Union National Bank. Marckx has been quoted in The Wall Street Journal, Barron's, Bloomberg Businessweek and Kiplinger. His work has also been cited in various market studies and working papers including those from Massachusetts Institute of Technology, Deloitte & Touche, and Pharmaceutical Manufacturing. He graduated with a bachelor's degree in finance from St. John Fisher College, and received his master's degree in business administration from Wake Forest University. Marckx is also a Chartered Financial Analyst.

Recent Quotes

"DRRX's licensing agreement with Gilead validates the SABER technology."

— Brian Marckx, Zacks Small-Cap Research (8/19/19)
more >

Due to permission requirements, not all quotes are shown.